Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 71, Issue -, Pages 729-738Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2016.10.018
Keywords
Autism spectrum disorders; microRNA; Epigenetic; Biomarkers
Categories
Funding
- National Research Agency under the Investments for the Future program [ANR-10-IHU-01]
- ANR-SAMENTA program
- Fondation pour la Recherche Medicale [DEQ20120323702]
- Fondation de France
- Centre National de la Recherche Scientifique
- Credit Agricole d'Ile-de-France Mecenat
Ask authors/readers for more resources
Autism spectrum disorders (ASD) are heritable neurodevelopmental conditions characterized by impairment in social interaction and communication and restricted, repetitive, stereotyped patterns of behavior. ASD likely involve deregulation of multiple genes related to brain function and development. MicroRNAs (miRNAs) are post-transcriptional regulators that play key roles in brain development, synapse formation and fine-tuning of genes underlying synaptic plasticity and memory formation. Here, we review recent studies providing genetic and molecular links between miRNA deregulation and ASD pathophysiology. These findings highlight the potential of miRNAs as both biomarkers and therapeutic tools in ASD. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available